Why One Small Company — About to Take on an Industry Giant — Won’t Compete on Price

So to strip things down to the basics, most cost-effectiveness analyses of drugs look at only three components: 1) What does it cost? 2) How does it extend or improve

Grad Szn is almost done, but I need to celebrate my oldest, who is graduating from McGill on Monday. Montreal in June is pretty spectacular, so Curve will be off

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.